Can exercise save your muscles while on Weight-Loss drugs? new trial aims to find out
NCT ID NCT07609160
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test whether a 24-week home-based resistance exercise program, when added to the weight-loss drug tirzepatide, helps overweight and obese adults maintain muscle mass and strength. About 108 people starting tirzepatide will be randomly assigned to either exercise plus the drug or the drug alone. Researchers will measure changes in thigh muscle thickness and quality using ultrasound.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
tirzepatide
What this could lead to
If successful, this could show that combining exercise with tirzepatide helps overweight people lose weight while keeping muscle strength and quality.
What could go wrong
This is a small, early-stage trial (108 people) that hasn't started yet. The exercise is home-based, so results may vary, and tirzepatide can cause side effects like nausea or digestive issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••